← All organizations
Worldwide Clinical Trials
For profitWebsite ↗
Also known as: WCT Worldwide Clinical Trials | WCT Worldwide Clinical Trials GER GmbH Germany | Worldwide Clinical Trails | Worldwide Clinical Trials | Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research) | Worldwide Clinical Trials Early Phase Services
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2007Last known activity
Dec 31, 2025
Timeline
1990s
- Jun 1, 1996
Worldwide Clinical Trials— Founded
2010s
- Sep 23, 2010
CEDRA Clinical Research— Acquired
Drugs by trial phase (91 distinct, 135 trials)
Phase 4 (6 own, 1 via acquisition)
Phase 3 (12 own, 3 via acquisition)
Phase 2 (25 own, 1 via acquisition)
Phase 1 (26 own, 8 via acquisition)
Other trials (4 own, 5 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
- Anemia, Iron-Deficiency
- Carcinoma, Non-Small-Cell Lung
- Cognitive Dysfunction
- Deafness
- Dementia
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Endometrial Neoplasms
- Familial Primary Pulmonary Hypertension
- Hearing Loss
- Hearing Loss, Sensorineural
- Heart Failure
- Hypertension
- Infarction
- Lewy Body Disease
- Lymphoma, Non-Hodgkin
- Motor Neuron Disease
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myocardial Infarction
- Opioid-Related Disorders
- Parkinson Disease
- Parkinsonian Disorders
- Postoperative Pain
- Psoriasis
- Psychotic Disorders
- Radiculopathy
- Schizophrenia
- Schnitzler Syndrome
- Sclerosis
- Seizures
- Syndrome
- Toothache
- Urticaria
- Vasculitis
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT06321705CollaboratorN/A—
- NCT06963216CollaboratorPhase 3Dec 31, 2025
- NCT07115329CollaboratorPhase 2Nov 30, 2025
- NCT06793397CollaboratorPhase 3Jul 8, 2025
- NCT06898450CollaboratorPhase 1/Phase 2Mar 31, 2025
- NCT06605105CollaboratorPhase 3Feb 23, 2025
- NCT06712407CollaboratorPhase 4Dec 15, 2024
- NCT06564818CollaboratorPhase 3Nov 30, 2024
- NCT06671938CollaboratorPhase 2Nov 22, 2024
- NCT06051721CollaboratorPhase 1/Phase 2Jan 6, 2024
- NCT06117020Overall official - principal investigatorPhase 1Sep 11, 2023
- NCT05721235CollaboratorPhase 4May 24, 2023
- NCT05716100CollaboratorPhase 3May 9, 2023
- NCT05869669CollaboratorPhase 2May 1, 2023
- NCT05718817CollaboratorPhase 3Apr 25, 2023
Details
- Founded
- Morrisville, NC, US Jun 1, 1996
- Last known activity
- Dec 31, 2025
Notes
CRO